Pages that link to "Q51936330"

The following pages link to Circulating angiogenic factors and placental abruption (Q51936330):

Displaying 37 items.

• Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration (Q26796661) (← links)
• Angiogenic factors in preeclampsia: potential for diagnosis and treatment (Q26825774) (← links)
• Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia (Q33349183) (← links)
• Pre-eclampsia part 1: current understanding of its pathophysiology (Q33416340) (← links)
• Risk of placental abruption in relation to migraines and headaches. (Q33729212) (← links)
• Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. (Q33815975) (← links)
• New developments in the pathogenesis of preeclampsia (Q33935675) (← links)
• Retrospective study of risk factors and maternal and fetal outcome in patients with abruptio placentae (Q34002936) (← links)
• Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid (Q34470845) (← links)
• An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study (Q34505090) (← links)
• Placental genome and maternal-placental genetic interactions: a genome-wide and candidate gene association study of placental abruption (Q34790582) (← links)
• Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes (Q35015402) (← links)
• Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review (Q35136184) (← links)
• Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications (Q35140024) (← links)
• Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease (Q35143007) (← links)
• Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study (Q36051943) (← links)
• Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia (Q36062460) (← links)
• Endothelin: Key Mediator of Hypertension in Preeclampsia (Q36073225) (← links)
• Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. (Q36106483) (← links)
• A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia (Q36189562) (← links)
• Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments (Q36189578) (← links)
• A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study (Q36221487) (← links)
• Low birthweight in relation to placental abruption and maternal thrombophilia status (Q36593703) (← links)
• Circulating soluble endoglin and placental abruption (Q36953051) (← links)
• A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma (Q36984261) (← links)
• Twin-to-twin transfusion syndrome: an antiangiogenic state? (Q37183878) (← links)
• Placental vascular pathology findings and pathways to preterm delivery (Q37306263) (← links)
• The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes (Q37489857) (← links)
• Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia (Q37935034) (← links)
• Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study (Q38458497) (← links)
• Ischemic placental syndrome--prediction and new disease monitoring. (Q38601408) (← links)
• Understanding biological mechanisms underlying adverse birth outcomes in developing countries: protocol for a prospective cohort (AMANHI bio-banking) study (Q43923824) (← links)
• Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition. (Q45333157) (← links)
• Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease (Q46729919) (← links)
• Biochemical markers of placental dysfunction in assisted conception (Q48717665) (← links)
• Role of Activin A in the Pathogenesis of Endothelial Cell Dysfunction in Preeclampsia (Q49351734) (← links)
• Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia. (Q52887370) (← links)